GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cryo-Cell International Inc (FRA:ZCY) » Definitions » 12-1 Month Momentum %

Cryo-Cell International (FRA:ZCY) 12-1 Month Momentum % : 69.08% (As of May. 28, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Cryo-Cell International 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-28), Cryo-Cell International's 12-1 Month Momentum % is 69.08%.

The industry rank for Cryo-Cell International's 12-1 Month Momentum % or its related term are showing as below:

FRA:ZCY's 12-1 Month Momentum % is ranked better than
92.43% of 647 companies
in the Healthcare Providers & Services industry
Industry Median: -11.76 vs FRA:ZCY: 69.08

Competitive Comparison of Cryo-Cell International's 12-1 Month Momentum %

For the Medical Care Facilities subindustry, Cryo-Cell International's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International's 12-1 Month Momentum % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's 12-1 Month Momentum % falls into.



Cryo-Cell International  (FRA:ZCY) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cryo-Cell International  (FRA:ZCY) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Cryo-Cell International 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Cryo-Cell International's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryo-Cell International (FRA:ZCY) Business Description

Traded in Other Exchanges
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.

Cryo-Cell International (FRA:ZCY) Headlines

No Headlines